OS Therapies Appoints New Chief Commercial and Financial Officers
OS Therapies has appointed Kerry Clem as Chief Commercial Officer and Frank Knuettel II as Chief Financial Officer. The new executives will focus on preparations for the commercial launch of the company's lead product candidate, Herlystic™.